Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page
- Check5 days agoChange DetectedThe new screenshot shows minor layout and styling tweaks that do not modify study content, eligibility criteria, locations, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check26 days agoChange DetectedMajor change: new version v3.2.0 plus a government operating status notice; removal of v3.1.0 indicates the update to the latest release.SummaryDifference2%

- Check40 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' link removed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.1%

- Check69 days agoChange DetectedThe web page has been updated to include new drug information and related topics, while some previous location and drug details have been removed. Notably, the facility name and specific location details have been added.SummaryDifference2%

Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.